RecruitingNot ApplicableNCT07143695

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion to Minimize Re-intubation Rate: a Randomized Controlled Trial


Sponsor

Cairo University

Enrollment

200 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria1

  • critically ill patient mechanically ventilated for 24 hours or more first spontaneous breathing trial

Exclusion Criteria1

  • patient refusal difficult ultrasound views tracheostomized patient neuromuscular disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEParasternal intercostal thickening fraction

Parasternal intercostal thickening fraction less than 6.5%

DEVICESham parasternal intercostal thickening

Ultrasound assessment only for purpose of blinding


Locations(1)

Cairo University

Cairo, Giza Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07143695


Related Trials